Novartis delivers better outcomes for patients through science-based innovation, addressing the evolving healthcare needs of society. Its products prevent and treat diseases, ease suffering and enhance quality of life. Novartis focuses on growing areas of healthcare where innovation plays an important role: pharmaceuticals, eye care and generic medicines. It is the only company with strong positions in all three areas. Research is at the heart of Novartis. It is driven by a distinctive strategy that focuses on areas of unmet medical need where the scientific tools to address that need are within reach. Corporate responsibility is integral to how Novartis operates and is key to its success. While Novartis products reach more than a billion people worldwide, the company continues to work to improve access to healthcare. Its Malaria Initiative is one of the largest access-to-medicine programmes in the healthcare industry. Headquartered in Basel, Switzerland, Novartis employs approximately 132,000 associates and operates in more than 180 countries.